Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007

Journal of Clinical Microbiology

Volumn 46, Issue 5, 2008, Pages 1672-1677

  André, Philippe ^a   Caro, Valerie ^b   Njamkepo, Elisabeth ^b   Wendelboe, Aaron M ^c   Van Rie, Annelies ^c   Guiso, Nicole ^b  

^a SANOFI PASTEUR   (France)

^b CNRS   (France)

^c The University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BORDETELLA PERTUSSIS; CHILD; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; LABORATORY; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROLOGY; YOUDEN INDEX;

ADOLESCENT; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; DNA TRANSPOSABLE ELEMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PERTUSSIS TOXIN; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WHOOPING COUGH;

BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS;

EID: 43249084521     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02187-07     Document Type: Article

References (29)

1. Anonymous. 2007. Calendrier vaccinal - avis du haut conseil de la santé publique. Bull. Epidemiol. Hebdomadaire 31-32:271-288.
2. Antila, M., Q. He, C. de Jong, I. Aarts, H. Verbakel, S. Bruisten, S. Keller, M. Haanpera, J. Makinen, E. Eerola, M. K. Viljanen, J. Mertsola, and A. van der Zee. 2006. Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J. Med. Microbiol. 55:1043-1051.
3. Baughman, A. L., K. M. Bisgard, K. M. Edwards, D. Guris, M. D. Decker, K. Holland, B. D. Meade, and F. Lynn. 2004. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol. 11:1045-1053.
4. Caro, V., V. Bouchez, N. Guiso, B. Gatti, M. R. Agosti, and S. E. Ayala. 2007. Pertussis in Argentina and France. Vaccine 25:4335-4339.
5. Caro, V., A. Elomaa, D. Brun, J. Mertsola, Q. He, and N. Guiso. 2006. Bordetella pertussis, Finland and France. Emerg. Infect. Dis. 12:987-989.
6. Caro, V., D. Hot, G. Guigon, C. Hubans, M. Arrive, G. Soubigou, G. Renauld-Mongenie, R. Antoine, C. Locht, Y. Lemoine, N. Guiso, V. Caro, A. Elomaa, D. Brun, J. Mertsola, Q. He, and N. Guiso. 2006. Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. Microbes Infect. 8:2228-2235.
7. Caro, V., E. Njamkepo, S. C. Van Amersfoorth, F. R. Mooi, A. Advani, H. O. Hallander, Q. He, J. Mertsola, M. Riffelmann, C. Vahrenholz, C. H. Von Konig, and N. Guiso. 2005. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect. 7:976-982.
8. Cherry, J. D., E. Grimprel, N. Guiso, U. Heininger, and J. Mertsola. 2005. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr. Infect. Dis. J. 24:S25-S34.
9. de Melker, H. E., F. G. Versteegh, J. F. Schellekens, P. F. Teunis, and M. Kretzschmar. 2006. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J. Infect. 53:106-113.
10. Edwards, K. M., and M. D. Decker. 2004. Pertussis vaccine, p. 471-528. In S. Plotkin, W. A. Orenstein, and P. A. Offit (ed.), Vaccines, 4th ed., vol. 21. Saunders, Philadelphia, PA.
11. Elomaa, A., A. Advani, D. Donnelly, M. Antila, J. Mertsola, H. Hallander, and Q. He. 2005. Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. J. Clin. Microbiol. 43:3681-3687.
12. Fluss, R., D. Faraggi, and B. Reiser. 2005. Estimation of the Youden Index and its associated cutoff point. Biom. J. 47:458-472.
13. Grimprel, E., P. Begue, I. Anjak, F. Betsou, and N. Guiso. 1993. Comparison of polymerase chain reaction, culture, and Western immunoblot serology for diagnosis of Bordetella pertussis infection. J. Clin. Microbiol. 31:2745-2750.
14. Guiso, N., C. Boursaux-Eude, C. Weber, S. Z. Hausman, H. Sato, M. Iwaki, K. Kamachi, T. Konda, and D. L. Burns. 2001. Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines. Vaccine 19:3248-3252.
15. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
16. Khelef, N., B. Danve, M. J. Quentin-Millet, and N. Guiso. 1993. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect. Immun. 61:486-490.
17. Kourova, N., V. Caro, C. Weber, S. Thiberge, R. Chuprinina, G. Tseneva, and N. Guiso. 2003. Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains. J. Clin. Microbiol. 41:3706-3711.
18. Kretsinger, K., K. R. Broder, M. M. Cortese, M. P. Joyce, I. Ortega-Sanchez, G. M. Lee, T. Tiwari, A. C. Cohn, B. A. Slade, J. K. Iskander, C. M. Mijalski, K. H. Brown, and T. V. Murphy. 2006. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm. Rep. 55:1-37.
19. Lambert, H. J. 2005. Epidemiology of a small pertussis outbreak in Kent County, Michigan. MMWR Recomm. Rep. 54:1283-1286.
20. Littmann, M., C. Huelbe, M. Riffelmann, and C. H. Wirsing von Konig. 2006. Persistence of antibodies to pertussis antigens after immunization of health care personnel with reduced dose acellular pertussis vaccines. Abstr. Eighth International Symposium: Saga of the Genus Bordetella, 1906-2006, abstr. E5-120. Institut Pasteur, Paris, France.
21. Lynn, F., G. F. Reed, and B. D. Meade. 1997. A comparison of enzyme immunoassays used to measure serum antibodies to components of Bordetella pertussis. Dev. Biol. Stand. 89:197-204.
22. Miller, W. C. 1998. Bias in discrepant analysis: when two wrongs don't make a right. J. Clin. Epidemiol. 51:219-231.
23. Mooi, F. R., H. Hallander, C. H. Wirsing von Köning, B. Hoet, and N. Guiso. 2000. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. Clin. Infect. Dis. J. 19:174-181.
24. Qin, X., E. Galanakis, E. T. Martin, and J. A. Englund. 2007. Multitarget PCR for diagnosis of pertussis and its clinical implications. J. Clin. Microbiol. 45:506-511.
25. Riffelmann, M., C. H. Wirsing von Konig, V. Caro, and N. Guiso. 2005. Nucleic acid amplification tests for diagnosis of Bordetella infections. J. Clin. Microbiol. 43:4925-4929.
26. Simondon, F., I. Iteman, M. P. Preziosi, A. Yam, and N. Guiso. 1998. Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal. Clin. Diagn. Lab. Immunol. 5:130-134.
27. Weber, C., C. Boursaux-Eude, G. Coralie, V. Caro, and N. Guiso. 2001. Polymorphism of Bordetella pertussis isolates circulating the last ten years in France, where a single effective whole-cell vaccine has been used for more than thirty years. J. Clin. Microbiol. 39:4396-4403.
28. Wendelboe, A. M., E. Njamkepo, A. Bourillon, D. D. Floret, J. Gaudelus, M. Gerber, E. Grimprel, D. Greenberg, S. Halperin, J. Liese, F. Munoz-Rivas, R. Teyssou, N. Guiso, and A. Van Rie. 2007. Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J. 26:293-299.
29. Youden, W. 1950. Index for rating diagnostic tests. Cancer 3:32-33.